Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-23-015639

Options or other derivatives

  • Director acquired 36,524 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Klencke Barbara Director 2023-06-13 Grant or award · Stock Option (Right to Buy) +36,524 36,524 D
Loading xslF345X04/doc4.xml…